Loading patent…
OwnerYolanda Sanz Herranz, Yolanda Arlette Santacruz +1inventors
InventorsYolanda Sanz Herranz, Yolanda Arlette Santacruz, Paola Gauffin
Estimating the term…
The present invention relates to the Bifidobacterium CECT 7765 strain, to its cell components, metabolites, and secreted molecules, to the combinations thereof with other microorganisms, and to compositions comprising the aforementioned products, as well as to the use of a strain of the Bifidobacterium pseudocatenulatum species, or to using the CECT 7765 strain for the prevention and/or treatment of obesity, overweight, hyperglycemia and diabetes, preferably type 2 diabetes mellitus, hepatic steatosis or fatty liver, dyslipidemia, metabolic syndrome, immune system dysfunction associated with obesity and overweight; and an unbalanced composition of the intestinal microbiota associated with obesity and overweight.
1-36. (canceled)
Bifidobacterium pseudocatenulatum strain with accession number CECT 7765 or a strain derived thereof.
A method for preparing a pharmaceutical composition, a medicinal product or a nutritive composition comprising formulating a strain of the B. pseudocatenulatum species into said pharmaceutical composition, a medicinal product or nutritive composition.
A method for the prevention and/or treatment of a disease selected from the group consisting of overweight, obesity, hyperglycemia, diabetes, hepatic steatosis, fatty liver, dyslipidemia, metabolic syndrome, infections in obese or overweight subjects and/or adipocyte hypertrophy said method comprising the administration of a strain of the B. pseudocatenulatum species to a subject in need thereof.
A method for improving the function of the immune system of an overweight subject or of an obese subject with respect to an untreated subject or for reducing intake and increasing the energy expenditure in a non-obese subject with respect to an untreated control subject, said method comprising said method comprising the administration of a strain of the B. pseudocatenulatum species to a subject in need thereof.
A method for reducing the synthesis of proinflammatory proteins at the peripheral and central level associated with the development of overweight, obesity, and related pathologies said method comprising the administration of a strain of the B. pseudocatenulatum species to a subject in need thereof.
A method for reducing the concentration of enterobacteria in the intestinal content with respect to an untreated control said method comprising the administration of a strain of the B. pseudocatenulatum species to a subject in need thereof.
Dependencies are inferred from the claim text.